# Ernexa Therapeutics Inc.: Form SC 13D/A, filed Aug 18, 2020

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D/A
- Filed: 2020-08-18
- Accepted by EDGAR: Aug 18, 2020, 17:12 ET
- Period: not reported
- Accession: 0001213900-20-022708
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000121390020022708/ea125713-f13da2ellin_ntn.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000121390020022708/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000121390020022708/ea125713-f13da2ellin_ntn.htm

Filed Aug 18, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-022708. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.